Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy
,aspect=ignore)
F.GolozoubovaV.RolinB.KnudsenL
In summary, GLP-1 RAs represent a promising therapeutic option for obese patients with HFpEF, but their large-scale adoption will require further evidence of efficacy, safety, and long-term benefits through rigorous and well-designed clinical trials
However, as more patients make their voices heard and doctors begin to prescribe them, obesity could become easier to treat or even cure
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are novel drugs approved for diabetes and obesity
US$ 23.45
US$ 29.84
US$ 27.54
US$ 27.02
